ArticleCancers2023

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction.

Margaret Cupit-Link et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.